Symbiosis Appoints Angelika Rublack as Senior Business Development Manager
Symbiosis Pharmaceutical Services (Symbiosis), a global contract manufacturing organisation (CMO) specialising in sterile manufacture of injectable drug products, has appointed Angelika Rublack as Senior Business Development Manager to support its expanding global client base and drive growth across several territories.
With 25 years of international sales and key account experience—16 in the pharmaceutical sector—Angelika brings expertise in sterile manufacturing and commercial fill-finish services. Previously at Siegfried, she held senior commercial roles, including Senior Business Development Manager and Head of Sales Office. Based in Germany, Angelika will support Symbiosis’ expansion in the EU, US, and APAC regions by identifying new opportunities and building partnerships in the biopharmaceutical market. Her appointment reflects Symbiosis’ focus on global, client-oriented growth.
“I was drawn to Symbiosis because of the company’s clear dedication to meeting customer needs with passion, agility and transparency,” said Angelika. “Their culture of collaboration, strategic focus and customer-first mindset aligns perfectly with my experience and values. I’m excited to bring new partnerships to the business and becoming an integral part of Symbiosis’ continued success.”
In her role, Angelika will focus on identifying and securing new project opportunities and nurturing client relationships, leveraging her deep knowledge of complex stakeholder environments and her extensive experience in collaborative, cross-functional client engagement.
“Angelika brings invaluable expertise in sterile manufacturing and commercial fill/finish, and a proven track record of fostering trusted relationships across the biopharma sector,” said Colin MacKay, CEO of Symbiosis. “Her appointment enhances our business development capabilities across Europe as we continue to grow our international client base.”
